Lexicon Pharmaceuticals
LXRX
LXRX
120 hedge funds and large institutions have $240M invested in Lexicon Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 31 increasing their positions, 35 reducing their positions, and 33 closing their positions.
Holders
120
Holders Change
-7
Holders Change %
-5.51%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
31
Reduced
35
Closed
33
Calls
$689K
Puts
$62K
Net Calls
+$627K
Net Calls Change
+$321K
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$36.1M |
| 2 |
SC
2
Sessa Capital
New York
|
$2.84M |
| 3 |
GCP
3
GSA Capital Partners
London,
United Kingdom
|
$2.68M |
| 4 |
4
Millennium Management
New York
|
$1.55M |
| 5 |
5
Jane Street
New York
|
$761K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$3.17M |
| 2 |
SSA
2
Schonfeld Strategic Advisors
New York
|
$4.33M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$774K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$379K |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$2.25M |
